Skip to main content
OpenTrials

Clinical trial condition

Granuloma, Plasma Cell

Explore clinical trials studying Granuloma, Plasma Cell. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Granuloma, Plasma Cell trial results

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions
Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 381 locations
View Trial Details
Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions
Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Bergonie Bordeaux, France
  • Centre Georges-Francois-Leclerc Dijon, France
View all 25 locations
View Trial Details
Completed

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

NCT01742286

Conditions
ALK-activated Tumors, Granuloma, Granuloma, Plasma Cell, +26 more
Locations
  • Dana Farber Cancer Institute Dept of Onc Boston, Massachusetts, United States
  • Memorial Sloan Kettering SC - 7 New York, United States
  • Cincinnati Children s Hospital Medical Center Dept of Oncology Cincinnati, Ohio, United States
  • St Jude s Childrens Research Hospital Dept of Oncology Memphis, Tennessee, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Crizotinib Continuation Clinical Study

NCT05160922

Conditions
ALCL, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Province Oncology Hospital Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details

Related conditions